International Clinical Psychopharmacology

1-9 of 9
 
Check/Uncheck all
  • 2019 Journal Article | 
    ​ ​Efficacy of venlafaxine extended release in major depressive disorder patients: ​effect of baseline anxiety symptom severity​
    Lyndon, G. J.; Prieto, R.; Wajsbrot, D. B.; Allgulander, C. & Bandelow, B.​ (2019) 
    International Clinical Psychopharmacology34(3) pp. 110​-118​.​ DOI: https://doi.org/10.1097/YIC.0000000000000256 
    Details  DOI  PMID  PMC 
  • 2018 Journal Article
    ​ ​Use of antidementia drugs in German patients with Alzheimer’s disease​
    Dodel, R.; Baum, E.; Müller, M. J.; Paschke, G.; Zeidler, J.; Klora, M. & Reese, J.-P. et al.​ (2018) 
    International Clinical Psychopharmacology33(2) pp. 103​-110​.​ DOI: https://doi.org/10.1097/YIC.0000000000000205 
    Details  DOI 
  • 2018 Journal Article
    ​ ​Continuity of treatment with benzodiazepines in dementia patients: an analysis of German health insurance claims data​
    Hessmann, P. ; Zeidler, J.; Neubauer, S.; Abdel-Hamid, M. ; Stahmeyer, J.; Eberhard, S. & Wolff-Menzler, C.  et al.​ (2018) 
    International Clinical Psychopharmacology33(5) pp. 282​-289​.​ DOI: https://doi.org/10.1097/YIC.0000000000000230 
    Details  DOI  PMID  PMC 
  • 2016 Journal Article
    ​ ​Treatment patterns and characteristics of older antipsychotic users in Germany​
    Schmedt, N.; Jobski, K.; Kollhorst, B.; Krappweis, J.; Rüther, E. ; Schink, T. & Garbe, E.​ (2016) 
    International Clinical Psychopharmacology31(3) pp. 159​-169​.​ DOI: https://doi.org/10.1097/YIC.0000000000000119 
    Details  DOI  PMID  PMC  WoS 
  • 2015 Journal Article
    ​ ​Efficacy of treatments for anxiety disorders: a meta-analysis​
    Bandelow, B.; Reitt, M.; Roever, C. ; Michaelis, S.; Goerlich, Y. & Wedekind, D.​ (2015) 
    International Clinical Psychopharmacology30(4) pp. 183​-192​.​ DOI: https://doi.org/10.1097/YIC.0000000000000078 
    Details  DOI  PMID  PMC  WoS 
  • 2009 Journal Article
    ​ ​Efficacy of pregabalin and venlafaxine-XR in generalized anxiety disorder: results of a double-blind, placebo-controlled 8-week trial​
    Kasper, S.; Herman, B.; Nivoli, G.; van Ameringen, M.; Petralia, A.; Mandel, F. S. & Baldinetti, F. et al.​ (2009) 
    International Clinical Psychopharmacology24(2) pp. 87​-96​.​ DOI: https://doi.org/10.1097/YIC.0b013e32831d7980 
    Details  DOI  PMID  PMC  WoS 
  • 2006 Conference Paper
    ​ ​Pharmacology of a new antidepressant: benefit of the implication of the melatonergic system​
    Fuchs, E.; Simon, M. & Schmelting, B.​ (2006)
    International Clinical Psychopharmacology21 pp. S17​-S20. ​Satellite Symposium on Acting on Melatonergic Receptors held at the 18th ECNP Congress​, Amsterdam, NETHERLANDS.
    Philadelphia​: Lippincott Williams & Wilkins. DOI: https://doi.org/10.1097/01.yic.0000199456.39552.c7 
    Details  DOI  PMID  PMC  WoS 
  • 2001 Journal Article
    ​ ​A 28-week, double-blind, placebo-controlled study with Cerebrolysin in patients with mild to moderate Alzheimer's disease​
    Ruether, E.; Husmann, R.; Kinzler, E.; Diabl, E.; Klingler, D.; Spatt, J. & Ritter, R. et al.​ (2001) 
    International Clinical Psychopharmacology16(5) pp. 253​-263​.​ DOI: https://doi.org/10.1097/00004850-200109000-00002 
    Details  DOI  PMID  PMC  WoS 
  • 2000 Journal Article
    ​ ​Increased psychological responses and divergent neuroendocrine responses to m-CPP and ipsapirone in patients with panic disorder​
    Broocks, A.; Bandelow, B.; George, A.; Jestrabeck, C.; Opitz, M.; Bartmann, U. & Gleiter, C. H. et al.​ (2000) 
    International Clinical Psychopharmacology15(3) pp. 153​-161​.​ DOI: https://doi.org/10.1097/00004850-200015030-00004 
    Details  DOI  PMID  PMC  WoS 

Type

Date issued

Publication Affiliation

Fulltext

Options

Citation Style

Sort

Issue Date
Title

Embed

JavaScript
Link

Export

Activate Export Mode
Deactivate Export Mode

Select some or all items (max. 800 for CSV/Excel) from the publications list, then choose an export format below.